The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits

Although there are numerous studies regarding Alzheimer's disease (AD), the cause and progression of AD are still not well understood. The researches in the past decade implicated amyloid-beta (Aβ) overproduction as a causative event in disease pathogenesis, but still failed to clarify the mechanism of pathology from Aβ production to central neural system defects in AD. The present review raises the hypothesis that the onset of AD pathology is closely related with mitochondrial dysfunction induced by Aβ and brain-derived neurotrophic factor (BDNF) axonal transport deficits. It is well-known that axonal transport defect and attenuation of BDNF-neurotrophic tyrosine receptor kinase 2 (TrkB) signal are fatal to neuronal function and survival. We hypothesized that abnormal amyloid precursor protein (APP) processing and Aβ production in mitochondria disturb the axonal transport by impairing mitochondrial function and attenuate BDNF-neurotrophic tyrosine receptor kinase 2 signal subsequently. For this hypothesis, the factors related with the initiation of AD pathology are not only limited to the neurons per se but also expanded to the microenvironment around neurons, such as the secretion of BDNF from astrocytes. The modification of the origin in this pathway may contribute to slow down the disease progression of AD.

[1]  A. Minarini,et al.  Alzheimer's disease: new approaches to drug discovery. , 2009, Current opinion in chemical biology.

[2]  C. Haass,et al.  Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis* , 2004, Journal of Biological Chemistry.

[3]  F. Gomez-Pinilla,et al.  Coupling energy metabolism with a mechanism to support brain-derived neurotrophic factor-mediated synaptic plasticity , 2006, Neuroscience.

[4]  T. Goldberg,et al.  BNDF modulates normal human hippocampal ageing , 2010, Molecular Psychiatry.

[5]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[6]  H. Scharfman,et al.  Brain-derived neurotrophic factor. , 2004, Growth factors.

[7]  Kai Zhang,et al.  Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.

[8]  C. Cotman,et al.  β-Amyloid impairs axonal BDNF retrograde trafficking , 2011, Neurobiology of Aging.

[9]  Qian Cai,et al.  Mitochondrial transport and docking in axons , 2009, Experimental Neurology.

[10]  P. Barker p75NTR Is Positively Promiscuous Novel Partners and New Insights , 2004, Neuron.

[11]  E. Cattaneo,et al.  Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.

[12]  C. Masters,et al.  Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42 , 2005, The Journal of Neuroscience.

[13]  A. Grierson,et al.  Role of axonal transport in neurodegenerative diseases. , 2008, Annual review of neuroscience.

[14]  D. Galati,et al.  Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction , 2006, The Journal of Neuroscience.

[15]  R. Tanzi,et al.  The Genetics of Alzheimer Disease: Back to the Future , 2010, Neuron.

[16]  K. Lo,et al.  Dynactin regulates bidirectional transport of dense-core vesicles in the axon and dendrites of cultured hippocampal neurons , 2009, Neuroscience.

[17]  M. Hayashi,et al.  A New Aspect of the TrkB Signaling Pathway in Neural Plasticity , 2009, Current neuropharmacology.

[18]  H. Atamna,et al.  Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. , 2007, Mitochondrion.

[19]  L. Bergersen,et al.  Mitochondrial DNA toxicity compromises mitochondrial dynamics and induces hippocampal antioxidant defenses. , 2011, DNA repair.

[20]  M. Robin,et al.  Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells , 2003, The Journal of cell biology.

[21]  L. Buée,et al.  Neurotrophic factors in Alzheimer’s disease: role of axonal transport , 2008, Genes, brain, and behavior.

[22]  M. Beal,et al.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. , 2008, Trends in molecular medicine.

[23]  L. Minichiello TrkB signalling pathways in LTP and learning , 2009, Nature Reviews Neuroscience.

[24]  E. Holzbaur,et al.  Axonal transport and neurodegenerative disease. , 2006, Biochimica et biophysica acta.

[25]  S. Sensi,et al.  Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction , 2010, Cell Death and Disease.

[26]  Xiongwei Zhu,et al.  Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons , 2010, Neurodegenerative Diseases.

[27]  A. Eckert,et al.  Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects , 2010, Molecular Neurobiology.

[28]  P. Hollenbeck,et al.  Mitochondrial movement and positioning in axons: the role of growth factor signaling , 2003, Journal of Experimental Biology.

[29]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[30]  B. Winblad,et al.  Mitochondrial γ‐secretase participates in the metabolism of mitochondria‐associated amyloid precursor protein , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  N. Seidah,et al.  Biosynthesis and Post-translational Processing of the Precursor to Brain-derived Neurotrophic Factor* , 2001, The Journal of Biological Chemistry.

[32]  G. Yancopoulos,et al.  The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins , 1994, Neuron.

[33]  P. Reddy,et al.  Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. , 2011, Biochimica et biophysica acta.

[34]  N. Seidah,et al.  Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases , 1996, FEBS letters.

[35]  Russell H. Swerdlow,et al.  The Alzheimer's disease mitochondrial cascade hypothesis: An update , 2009, Experimental Neurology.

[36]  Daniel Irimia,et al.  Differential effect of three‐repeat and four‐repeat tau on mitochondrial axonal transport , 2009, Journal of neurochemistry.

[37]  M. Frotscher,et al.  Complete Deletion of the Neurotrophin Receptor p75NTRLeads to Long-Lasting Increases in the Number of Basal Forebrain Cholinergic Neurons , 2002, The Journal of Neuroscience.

[38]  F. Müller-Spahn,et al.  Amyloid-beta Leads to Impaired Cellular Respiration, Energy Production and Mitochondrial Electron Chain Complex Activities in Human Neuroblastoma Cells , 2009, Cellular and Molecular Neurobiology.

[39]  D. Dickson,et al.  Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies , 1997, Neurobiology of Aging.

[40]  Eran Perlson,et al.  Retrograde axonal transport: pathways to cell death? , 2010, Trends in Neurosciences.

[41]  A. Aschrafi,et al.  Regulation of axonal trafficking of cytochrome c oxidase IV mRNA , 2010, Molecular and Cellular Neuroscience.

[42]  Bai Lu,et al.  Regulation of TrkB receptor tyrosine kinase and its internalization by neuronal activity and Ca2+ influx , 2003, The Journal of cell biology.

[43]  Petti T. Pang,et al.  The yin and yang of neurotrophin action , 2005, Nature Reviews Neuroscience.

[44]  J. Bennett,et al.  The mitochondrial secret(ase) of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[45]  Kefei Chen,et al.  Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease , 2005, Genes, brain, and behavior.

[46]  V. Papadopoulos,et al.  Alzheimer's disease: effects of β-amyloid on mitochondria. , 2011, Mitochondrion.

[47]  S. Yan,et al.  Role of mitochondrial amyloid-beta in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[48]  D. Butterfield,et al.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment , 2009, Journal of bioenergetics and biomembranes.

[49]  J. Quinn,et al.  Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. , 2004, Human molecular genetics.

[50]  D. Shepherd,et al.  Aβ exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease , 2010, Experimental Neurology.

[51]  Xiao-jiang Sun,et al.  Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila , 2010, The Journal of Neuroscience.

[52]  Richard Mayeux,et al.  Clinical practice. Early Alzheimer's disease. , 2010, The New England journal of medicine.

[53]  D. Chan,et al.  Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases , 2009, Human molecular genetics.

[54]  Han Lin,et al.  Increased Human Wildtype Tau Attenuates Axonal Transport Deficits Caused by Loss of APP in Mouse Models. , 2010, Magnetic resonance insights.

[55]  Robia G. Pautler,et al.  Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease , 2010, PloS one.

[56]  F. LaFerla,et al.  Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. , 2010, Journal of Alzheimer's disease : JAD.

[57]  M. Tuszynski,et al.  Potential therapeutic uses of BDNF in neurological and psychiatric disorders , 2011, Nature Reviews Drug Discovery.

[58]  S. Liu,et al.  Catalpol ameliorates beta amyloid–induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors , 2009, Neuroscience.

[59]  Xiongwei Zhu,et al.  Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins , 2008, Proceedings of the National Academy of Sciences.

[60]  P. Hollenbeck,et al.  The axonal transport of mitochondria , 2005, Journal of Cell Science.

[61]  H. Braak,et al.  Evolution of neuronal changes in the course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[62]  R. Segal,et al.  Selectivity in neurotrophin signaling: theme and variations. , 2003, Annual review of neuroscience.

[63]  R. Segal,et al.  Action in the axon: generation and transport of signaling endosomes , 2008, Current Opinion in Neurobiology.

[64]  P. Hollenbeck The pattern and mechanism of mitochondrial transport in axons. , 1996, Frontiers in bioscience : a journal and virtual library.

[65]  J. Schulz,et al.  Mitochondrial Protein Quality Control by the Proteasome Involves Ubiquitination and the Protease Omi* , 2008, Journal of Biological Chemistry.

[66]  Y. Barde,et al.  Global Deprivation of Brain-Derived Neurotrophic Factor in the CNS Reveals an Area-Specific Requirement for Dendritic Growth , 2010, The Journal of Neuroscience.

[67]  B. Winblad,et al.  Nicastrin, Presenilin, APH-1, and PEN-2 Form Active γ-Secretase Complexes in Mitochondria* , 2004, Journal of Biological Chemistry.

[68]  Xiongwei Zhu,et al.  Mitochondrial biology in Alzheimer’s disease pathogenesis , 2010, Journal of neurochemistry.

[69]  Dimitrios Kapogiannis,et al.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.

[70]  K. Kaibuchi,et al.  Anterograde transport of TrkB in axons is mediated by direct interaction with Slp1 and Rab27. , 2009, Developmental cell.

[71]  M. Barbacid,et al.  The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3 , 1991, Cell.

[72]  R. Segal,et al.  Dynein motors transport activated Trks to promote survival of target-dependent neurons , 2004, Nature Neuroscience.

[73]  N. Matsuoka,et al.  Advances in small molecules promoting neurotrophic function. , 2007, Pharmacology & therapeutics.

[74]  J. Bueller,et al.  Involvement of BDNF in Age-Dependent Alterations in the Hippocampus , 2010, Front. Ag. Neurosci..

[75]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[76]  B. Gilchrest,et al.  Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. , 1997, The Journal of clinical investigation.

[77]  Xiaomin Song,et al.  Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice , 2009, Proceedings of the National Academy of Sciences.

[78]  G. Leo,et al.  A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: possible relevances for the Alzheimer's disease , 2010 .

[79]  S. Ferreira,et al.  Amyloid-β Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3β in Primary Cultured Hippocampal Neurons , 2010, The Journal of Neuroscience.

[80]  R. Pautler,et al.  Convergence of Presenilin- and Tau-Mediated Pathways on Axonal Trafficking and Neuronal Function , 2010, The Journal of Neuroscience.

[81]  D. Wilcock,et al.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.

[82]  D. Geschwind,et al.  Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease , 2009, Nature Medicine.

[83]  T. Kawakami,et al.  Glutamate and Amyloid β-Protein Rapidly Inhibit Fast Axonal Transport in Cultured Rat Hippocampal Neurons by Different Mechanisms , 2003, The Journal of Neuroscience.

[84]  D. Shelton,et al.  Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[85]  George Perry,et al.  Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease , 2009, The Journal of Neuroscience.

[86]  M. Bilgen,et al.  Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. , 2010, The Journal of clinical investigation.

[87]  H. Braak,et al.  Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship , 2009, Journal of neuropathology and experimental neurology.

[88]  B. Fox,et al.  β-Amyloid1–42 Induces Neuronal Death through the p75 Neurotrophin Receptor , 2008, The Journal of Neuroscience.

[89]  B. Winblad,et al.  The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae , 2008, Proceedings of the National Academy of Sciences.

[90]  G. McKhann,et al.  Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model , 2010, Proceedings of the National Academy of Sciences.

[91]  J. Wuu,et al.  Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease , 2006, Journal of neurochemistry.

[92]  J. Quinn,et al.  Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.

[93]  L. Goldstein,et al.  Axonal transport and Alzheimer's disease. , 2006, Annual review of biochemistry.

[94]  Jing Huang,et al.  Brain-derived neurotrophic factor induces proliferation, migration, and VEGF secretion in human multiple myeloma cells via activation of MEK-ERK and PI3K/AKT signaling , 2010, Tumor Biology.

[95]  Barbara L. Hempstead,et al.  ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTR and Sortilin , 2005, The Journal of Neuroscience.

[96]  M. Beal,et al.  Neuroprotective strategies involving ROS in Alzheimer disease. , 2011, Free radical biology & medicine.

[97]  C. Duarte,et al.  Regulation of local translation at the synapse by BDNF , 2010, Progress in Neurobiology.